Ingevity未能预测财报，并下调了2026年展望，导致股价下跌。 Ingevity missed earnings estimates and lowered 2026 outlook, sending stock down.

英格维蒂报告第四季度每股收益为0.58美元,缺少0.74美元的共识,并更新了其2026年全年收益预测,为每股4.805.20美元. Ingevity reported fourth-quarter earnings of $0.58 per share, missing the $0.74 consensus, and updated its 2026 full-year earnings guidance to $4.80–$5.20 per share. 库存量比平均数下降了1.25美元至69.87美元。 The stock fell $1.25 to $69.87 on above-average volume. 该公司总部设在南卡罗来纳州North Charleston,在性能化学品和性能材料部分开展业务。 The company, based in North Charleston, South Carolina, operates in Performance Chemicals and Performance Materials segments. 分析员保持一种混杂的评级,有共识的“等待”和67.50美元的目标。 Analysts maintain a mixed rating with a consensus “Hold” and a $67.50 target.